ctDNA can predict risk of colon cancer recurrence, identify those most likely to benefit from chemotherapy
A study conducted by Ludwig Johns Hopkins researchers, their colleagues at Johns Hopkins University and Ludwig alumni at the Walter and Eliza Hall Institute of Medical Research (WEHI), in Melbourne, examined whether circulating ...
Sep 20, 2022
0
64